David Demski Net Worth

The estimated Net Worth of David M Demski is at least $55.1 Million dollars as of 21 August 2024. Mr. Demski owns over 50,000 units of Globus Medical Inc stock worth over $19,980,308 and over the last 12 years he sold GMED stock worth over $31,632,892. In addition, he makes $3,449,790 as President, Chief Executive Officer, and Director at Globus Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Demski GMED stock SEC Form 4 insiders trading

David has made over 21 trades of the Globus Medical Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of GMED stock worth $283,500 on 21 August 2024.

The largest trade he's ever made was exercising 330,000 units of Globus Medical Inc stock on 6 August 2020 worth over $11,919,600. On average, David trades about 51,078 units every 113 days since 2012. As of 21 August 2024 he still owns at least 288,441 units of Globus Medical Inc stock.

You can see the complete history of Mr. Demski stock trades at the bottom of the page.

David Demski biography

David M. Demski serves as President, Chief Executive Officer, Director of the Company. He currently serves as Chief Executive Officer, Director of the Company. He served as our President and Chief Operating Officer from August 2008 until September 2015 and as our Chief Financial Officer from 2003 until August 2008. Prior to joining Globus in 2003, Mr. Demski founded Cornerstone Capital LBO Fund, a boutique leveraged-buyout consultancy. Mr. Demski’s experience also includes serving as Vice President for Gilo Ventures, a Silicon Valley-based venture capital fund, from 2000 to 2001, and serving as Chief Operating Officer of Rendall and Associates, a telecommunications-focused consulting firm, from 1994 to 2000. He also managed regional and international distribution for Domino’s Pizza during the company’s growth in the late 1980s. Previously, he was an audit supervisor for Peat, Marwick, Mitchell & Company. Mr. Demski received a B.S. in Business Administration from the University of Michigan and an M.B.A. from the Stanford Graduate School of Business. Mr. Demski’s extensive leadership and experience at our Company and knowledge of our finances and operations, including as one of the founders of our Company, as well as his prior experience in the investing and auditing industries, bring to our Board of Directors critical strategic planning, financial, operations and leadership skills and qualify him to serve as one of our directors.

What is the salary of David Demski?

As the President, Chief Executive Officer, and Director of Globus Medical Inc, the total compensation of David Demski at Globus Medical Inc is $3,449,790. There are no executives at Globus Medical Inc getting paid more.

How old is David Demski?

David Demski is 62, he's been the President, Chief Executive Officer, and Director of Globus Medical Inc since 2019. There are 3 older and 15 younger executives at Globus Medical Inc. The oldest executive at Globus Medical Inc is James Tobin, 75, who is the Independent Director.

What's David Demski's mailing address?

David's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.

Insiders trading at Globus Medical Inc

Over the last 12 years, insiders at Globus Medical Inc have traded over $375,265,297 worth of Globus Medical Inc stock and bought 2,005 units worth $99,824 . The most active insiders traders include David C Paul, Kurt Wheeler, and David M Demski. On average, Globus Medical Inc executives and independent directors trade stock every 42 days with the average trade being worth of $11,005,133. The most recent stock trade was executed by Leslie V Norwalk on 11 July 2024, trading 1,000 units of GMED stock currently worth $70,000.

What does Globus Medical Inc do?

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.

Complete history of Mr. Demski stock trades at Alphatec Inc, Globus Medical Inc, and Axonics Inc

Globus Medical Inc executives and stock owners

Globus Medical Inc executives and other stock owners filed with the SEC include:

• David Demski,
  President, Chief Executive Officer, Director
• David Paul,
  Executive Chairman of the Board
• Daniel Scavilla,
  Executive Vice President, Chief Commercial Officer
• David M. Demski,
  CEO, Pres & Director
• Kelly Huller,
  Senior Vice President, General Counsel, Corporate Secretary
• David C. Paul,
  Co-Founder & Exec. Chairman
• Daniel T. Scavilla,
  Exec. VP, Chief Commercial Officer & Pres of Trauma
• Keith Pfeil,
  Chief Financial Officer, Senior Vice President
• Keith W. Pfeil,
  Sr. VP & CFO
• Kelly G. Huller Esq.,
  Sr. VP & Gen. Counsel
• Ann Rhoads,
  Independent Director
• Robert Douglas,
  Independent Director
• James Tobin,
  Independent Director
• Daniel Lemaitre,
  Independent Director
• Steve Zarrilli,
  Independent Director
• David Davidar,
  Independent Director
• Richard Holifield,
  Exec. Officer
• Mike Reeder,
  Exec. Officer
• Steven M. Payne,
  VP & Controller
• A. Brett Murphy,
  Exec. VP of International Sales
• Brian J. Kearns,
  Sr. VP of Bus. Devel. & Investor Relations
• John A De Ford,
  
• Kurt Wheeler,
  Director
• Robert Liptak,
  Director
• Steven Payne,
  Chief Accounting Officer
• Anthony L Williams,
  President
• Stephen T Zarrilli,
  
• Leslie V Norwalk,
  
• Dan Wolterman,
  
• Dan Lemaitre,
  
• A Brett Murphy,
  Executive VP, US Sales
• Eric Schwartz,
  Senior VP and General Counsel
• Sachs & Cogoldman Sachs Gro...,
  
• Lifesciences I, L.P.Clarus ...,
  
• Sachs Pep 2004 Offshore Hol...,
  
• Richard A Baron,
  Senior VP and CFO
• Sachs Group Incgoldman Sach...,
  
• Sachs Private Equity Partne...,